Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 199

1.

Impact of race and gender on cardiac device implantations.

El-Chami MF, Hanna IR, Bush H, Langberg JJ.

Heart Rhythm. 2007 Nov;4(11):1420-6. Epub 2007 Aug 1.

PMID:
17954401
[PubMed - indexed for MEDLINE]
2.

Racial disparity in the utilization of implantable-cardioverter defibrillators among patients with prior myocardial infarction and an ejection fraction of <or=35%.

Thomas KL, Al-Khatib SM, Kelsey RC 2nd, Bush H, Brosius L, Velazquez EJ, Peterson ED, Gilliam FR.

Am J Cardiol. 2007 Sep 15;100(6):924-9. Epub 2007 Jun 27.

PMID:
17826371
[PubMed - indexed for MEDLINE]
3.

Extent of and reasons for nonuse of implantable cardioverter defibrillator devices in clinical practice among eligible patients with left ventricular systolic dysfunction.

LaPointe NM, Al-Khatib SM, Piccini JP, Atwater BD, Honeycutt E, Thomas K, Shah BR, Zimmer LO, Sanders G, Peterson ED.

Circ Cardiovasc Qual Outcomes. 2011 Mar;4(2):146-51. doi: 10.1161/CIRCOUTCOMES.110.958603. Epub 2011 Feb 8.

PMID:
21304098
[PubMed - indexed for MEDLINE]
Free Article
4.

Implantable cardiac device procedures in older patients: use and in-hospital outcomes.

Swindle JP, Rich MW, McCann P, Burroughs TE, Hauptman PJ.

Arch Intern Med. 2010 Apr 12;170(7):631-7. doi: 10.1001/archinternmed.2010.30.

PMID:
20386008
[PubMed - indexed for MEDLINE]
5.

Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure.

Hernandez AF, Fonarow GC, Liang L, Al-Khatib SM, Curtis LH, LaBresh KA, Yancy CW, Albert NM, Peterson ED.

JAMA. 2007 Oct 3;298(13):1525-32.

PMID:
17911497
[PubMed - indexed for MEDLINE]
6.

Implantable cardioverter-defibrillator prescription in the elderly.

Epstein AE, Kay GN, Plumb VJ, McElderry HT, Doppalapudi H, Yamada T, Shafiroff J, Syed ZA, Shkurovich S; ACT Investigators.

Heart Rhythm. 2009 Aug;6(8):1136-43. doi: 10.1016/j.hrthm.2009.04.010. Epub 2009 Apr 10.

PMID:
19539542
[PubMed - indexed for MEDLINE]
7.

Influence of diabetes on cardiac resynchronization therapy with or without defibrillator in patients with advanced heart failure.

Ghali JK, Boehmer J, Feldman AM, Saxon LA, Demarco T, Carson P, Yong P, Galle EG, Leigh J, Ecklund FL, Bristow MR.

J Card Fail. 2007 Nov;13(9):769-73.

PMID:
17996827
[PubMed - indexed for MEDLINE]
8.

Competing risk analysis of cause-specific mortality in patients with an implantable cardioverter-defibrillator: The EVADEF cohort study.

Marijon E, Trinquart L, Otmani A, Waintraub X, Kacet S, Clémenty J, Chatellier G, Le Heuzey JY; Evaluation Médico-Economique du Défibrillateur Automatique Implantable (EVADEF) Investigators.

Am Heart J. 2009 Feb;157(2):391-397.e1. doi: 10.1016/j.ahj.2008.09.023. Epub 2008 Dec 3.

PMID:
19185651
[PubMed - indexed for MEDLINE]
9.

Design and implementation of a population-based registry of Implantable Cardioverter Defibrillators (ICDs) in Ontario.

Lee DS, Birnie D, Cameron D, Crystal E, Dorian P, Gula LJ, Healey JS, Janmohammed A, Khaykin Y, Krahn AD, LeFeuvre C, Simpson CS, Yee R, Hardy J, Slaughter PM, Chen Z, Alter DA, Laupacis A, Tu JV; Population-Based Registry of Implantable Cardioverter Defibrillators.

Heart Rhythm. 2008 Sep;5(9):1250-6. doi: 10.1016/j.hrthm.2008.05.015. Epub 2008 May 24.

PMID:
18774098
[PubMed - indexed for MEDLINE]
10.

Prognostic value of electrocardiographic measurements before and after cardiac resynchronization device implantation in patients with heart failure due to ischemic or nonischemic cardiomyopathy.

Iler MA, Hu T, Ayyagari S, Callahan TD 4th, Civello KC, Thal SG, Wilkoff BL, Chung MK.

Am J Cardiol. 2008 Feb 1;101(3):359-63. doi: 10.1016/j.amjcard.2007.08.043. Epub 2007 Dec 21.

PMID:
18237600
[PubMed - indexed for MEDLINE]
11.

[Spanish Implantable Cardioverter-Defibrillator Registry. Third Official Report of the Spanish Society of Cardiology Working Group on Implantable Cardioverter-Defibrillators (2006)].

Peinado R, Torrecilla EG, Ormaetxe J, Alvarez M; Grupo de Trabajo de Desfibrilador Implantable.

Rev Esp Cardiol. 2007 Dec;60(12):1290-301. Spanish.

PMID:
18082095
[PubMed - indexed for MEDLINE]
Free Article
12.

Prognostic value of T-wave alternans in patients with heart failure due to nonischemic cardiomyopathy: results of the ALPHA Study.

Salerno-Uriarte JA, De Ferrari GM, Klersy C, Pedretti RF, Tritto M, Sallusti L, Libero L, Pettinati G, Molon G, Curnis A, Occhetta E, Morandi F, Ferrero P, Accardi F; ALPHA Study Group Investigators.

J Am Coll Cardiol. 2007 Nov 6;50(19):1896-904. Epub 2007 Oct 22.

PMID:
17980258
[PubMed - indexed for MEDLINE]
Free Article
13.

Evaluating sex differences in population-based utilization of implantable cardioverter-defibrillators: role of cardiac conditions and noncardiac comorbidities.

MacFadden DR, Tu JV, Chong A, Austin PC, Lee DS.

Heart Rhythm. 2009 Sep;6(9):1289-96. doi: 10.1016/j.hrthm.2009.05.017. Epub 2009 May 18.

PMID:
19695966
[PubMed - indexed for MEDLINE]
14.

Race and gender equality in health care: are we there yet?

Patel C, Yan GX.

Heart Rhythm. 2007 Nov;4(11):1427-9. Epub 2007 Aug 15. No abstract available.

PMID:
17954402
[PubMed - indexed for MEDLINE]
15.

Ethnic and racial disparities in cardiac resynchronization therapy.

Farmer SA, Kirkpatrick JN, Heidenreich PA, Curtis JP, Wang Y, Groeneveld PW.

Heart Rhythm. 2009 Mar;6(3):325-31. doi: 10.1016/j.hrthm.2008.12.018. Epub 2008 Dec 13.

PMID:
19251206
[PubMed - indexed for MEDLINE]
16.

Patient and physician determinants of implantable cardioverter defibrillator use in the heart failure population.

Chae SH, Koelling TM.

Congest Heart Fail. 2010 Jul-Aug;16(4):141-6. doi: 10.1111/j.1751-7133.2009.00139.x.

PMID:
20662865
[PubMed - indexed for MEDLINE]
17.

Gender differences in procedure-related adverse events in patients receiving implantable cardioverter-defibrillator therapy.

Peterson PN, Daugherty SL, Wang Y, Vidaillet HJ, Heidenreich PA, Curtis JP, Masoudi FA; National Cardiovascular Data Registry.

Circulation. 2009 Mar 3;119(8):1078-84. doi: 10.1161/CIRCULATIONAHA.108.793463. Epub 2009 Feb 16.

PMID:
19221223
[PubMed - indexed for MEDLINE]
Free Article
18.

Hospital variation and characteristics of implantable cardioverter-defibrillator use in patients with heart failure: data from the GWTG-HF (Get With The Guidelines-Heart Failure) registry.

Shah B, Hernandez AF, Liang L, Al-Khatib SM, Yancy CW, Fonarow GC, Peterson ED; Get With The Guidelines Steering Committee.

J Am Coll Cardiol. 2009 Feb 3;53(5):416-22. doi: 10.1016/j.jacc.2008.09.045.

PMID:
19179199
[PubMed - indexed for MEDLINE]
Free Article
19.

Left ventricular ejection fraction as criterion for implantation of an implantable cardioverter-defibrillator in heart failure patients undergoing surgical left ventricular reconstruction.

Mollema SA, Klein P, Heersche J, Schalij MJ, Van der Wall EE, Versteegh MI, Klautz RJ, Van Erven L, Bax JJ.

Pacing Clin Electrophysiol. 2009 Jul;32(7):913-7. doi: 10.1111/j.1540-8159.2009.02408.x.

PMID:
19572868
[PubMed - indexed for MEDLINE]
20.

Predictors of appropriate implantable cardioverter-defibrillator therapy during long-term follow-up of patients with coronary artery disease.

Blumer J, Wolber T, Hellermann J, Holzmeister J, Binggeli C, Duru F, Brunckhorst C.

Int Heart J. 2009 May;50(3):313-21.

PMID:
19506335
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk